Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Enrollment completed in first of two phase III studies for Sanctura XR

March 9, 2006

Novel agents for nephritis disclosed in recent Shionogi patent

March 8, 2006

Clinical study of pollen extract preparation in CNBP/CPPS

March 6, 2006

Novel pathway involved in ADPKD identified / News in Context

March 3, 2006

Fast track status for tolvaptan in autosomal dominant polycystic kidney disease

Feb. 27, 2006

Keryx inlicenses novel phosphate binder Zerenex

Feb. 17, 2006

Lilly and Boehringer Ingelheim amend Yentreve/AriClaim agreements

Feb. 17, 2006

Phase I study of lemuteporfin in BPH fails to meet primary efficacy objective

Feb. 16, 2006

Generic name bremelanotide approved for PT-141

Feb. 10, 2006

Protection for gentamicin-evoked nephrotoxicity / News in Context

Feb. 10, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...